$46M Pharmaceutical Company Stock-Drop Suit Gets Final Approval

( May 8, 2025, 9:21 AM EDT) -- TRENTON, N.J. — A $46 million settlement between current and former executives and members of the board of directors of a pharmaceutical company that went bankrupt during the proceeding and investors who alleged that the company violated federal securities law by making material misstatements that caused the price of the company’s stock to be artificially inflated has been granted final approval by a federal magistrate judge in New Jersey....